This list is an analysis based on recent market events. It's not an investment recommendation.
Founded in 1997 and headquartered in Xianju, China, Zhejiang Starry Pharmaceutical Co.,Ltd. specializes in the research, production, and global distribution of X-CT non-ionic contrast agents and fluoroquinolone pharmaceuticals, along with their key intermediates. The company's extensive range of contrast agent products includes iohexol (and its hydrolysate and iodide derivatives), ioversol, iopamidol, iomeprol, iopromide, cybeclamine, iodixanol, gadopentetic acid dimeglumine, and glutamate. For fluoroquinolones, their offerings feature levofloxacin (and its hydrochloride salt), levoflurane, levofluorocarboxylic acid, pazufloxacin, and pazufloxacin mesylate.
Show more...
FAQ
What is Zhejiang Starry Pharmaceutical stock price today?▼
The current price of 603520.SHG is ¥8.78 CNY — it has increased by +0% in the past 24 hours. Watch Zhejiang Starry Pharmaceutical stock price performance more closely on the chart.
What is Zhejiang Starry Pharmaceutical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Shanghai Stock Exchange exchange Zhejiang Starry Pharmaceutical stocks are traded under the ticker 603520.SHG.
Is Zhejiang Starry Pharmaceutical stock price growing?▼
603520.SHG stock has fallen by -2.98% compared to the previous week, the month change is a -0.68% fall, over the last year Zhejiang Starry Pharmaceutical has showed a -24.89% decrease.
What is Zhejiang Starry Pharmaceutical market cap?▼
Today Zhejiang Starry Pharmaceutical has the market capitalization of 3.85B
When is the next Zhejiang Starry Pharmaceutical earnings date?▼
Zhejiang Starry Pharmaceutical is going to release the next earnings report on October 29, 2026.
What is Zhejiang Starry Pharmaceutical revenue for the last year?▼
Zhejiang Starry Pharmaceutical revenue for the last year amounts to 2.21B CNY.
What is Zhejiang Starry Pharmaceutical net income for the last year?▼
603520.SHG net income for the last year is 10.23M CNY.
Does Zhejiang Starry Pharmaceutical pay dividends?▼
Yes, 603520.SHG dividends are paid semi-annual. The last dividend per share was 0.25 CNY. As of today, Dividend Yield (FWD)% is 3.42%.
How many employees does Zhejiang Starry Pharmaceutical have?▼
As of September 06, 2026, the company has 1,905 employees.
In which sector is Zhejiang Starry Pharmaceutical located?▼
Zhejiang Starry Pharmaceutical operates in the Health & Wellness sector.
When did Zhejiang Starry Pharmaceutical complete a stock split?▼
The last stock split for Zhejiang Starry Pharmaceutical was on June 17, 2022 with a ratio of 1.4:1.
Where is Zhejiang Starry Pharmaceutical headquartered?▼
Zhejiang Starry Pharmaceutical is headquartered in Taizhou, China.